SCHEMBL6358684

SCHEMBL6358684

CN(C)Cc1ncc2c(-c3ccccc3)csc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.40
ALDH1A1 P00352 6/20 0.40
KDM4E B2RXH2 4/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
TSHR P16473 2/20 0.39
MAPK1 P28482 2/20 0.39
RECQL P46063 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
DAPK3 O43293 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
ABL1 P00519 1/20 0.38
NTRK1 P04629 1/20 0.38
LCK P06239 1/20 0.38
CSF1R P07333 1/20 0.38
RET P07949 1/20 0.38
MET P08581 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2368935 0.84 ALDH1A1 (0.44) LMNAALDH1A1KDM4ESMN1; SMN2TSHR
SCHEMBL30341175 0.76 ALDH1A1 (0.46) LMNAALDH1A1KDM4ESMN1; SMN2TSHR
SCHEMBL31248556 0.76 LMNA (0.52) LMNAALDH1A1KDM4EMEN1KMT2A
SCHEMBL30341183 0.74 NPC1 (0.47) LMNAALDH1A1KDM4ESMN1; SMN2MAPK1
SCHEMBL2368300 0.73 ESR1 (0.47) LMNAALDH1A1KDM4EMEN1KMT2A
SCHEMBL14965210 0.73 ADORA1 (0.50) LMNAALDH1A1KMT2ASMN1; SMN2DAPK3
SCHEMBL6356763 0.73 SQOR (0.37) LMNAALDH1A1KDM4ETSHRMAPK1
SCHEMBL2368984 0.72 FGFR1 (0.41) LMNAALDH1A1MEN1KMT2ASMN1; SMN2
SCHEMBL2369195 0.72 DAPK3 (0.40) LMNAALDH1A1KDM4ESMN1; SMN2TSHR
SCHEMBL2368787 0.72 CYP1A2 (0.42) ALDH1A1KDM4ETDP1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050026935-A1 Compounds XENTION DISCOVERY LTD. 2005-02-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050026935-A1 Compounds KCNJ11, KCNJ1, KCNH1 LMNA 1126/4885ALDH1A1 247/4885KDM4E 1880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.